Cagrilintide is a synthetic analogue of the naturally occurring hormone amylin, co-secreted with insulin by pancreatic beta cells. It is engineered for enhanced stability and a longer half-life, making it suitable for prolonged action in research models.
In metabolic research, Cagrilintide is investigated for its ability to:
-
Modulate appetite and satiety signals through activation of amylin receptors in the brain (particularly the area postrema and nucleus tractus solitarius).
-
Delay gastric emptying, which may influence nutrient absorption and postprandial glucose response.
-
Support weight loss studies, especially when combined with GLP-1 receptor agonists like semaglutide or liraglutide.
Preclinical models have demonstrated synergistic effects when Cagrilintide is co-administered with other incretin mimetics, offering a novel multi-pathway approach to obesity and metabolic syndrome.
Reconstitution Instructions:
Reconstitute with BAC water. Refrigerate after reconstitution and use under sterile research conditions. Use our Peptide Calculator
For laboratory research use only. Not for human consumption.
Reviews
There are no reviews yet.